Literature DB >> 32753388

Brain Tau Imaging: Food and Drug Administration Approval of 18F-Flortaucipir Injection.

Venkata S Mattay1, Anthony F Fotenos1, Charles J Ganley2, Libero Marzella3.   

Abstract

Entities:  

Year:  2020        PMID： 32753388     DOI： 10.2967/jnumed.120.252254

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  5 in total

1.  TauIQ: A Canonical Image Based Algorithm to Quantify Tau PET Scans.

Authors:  Alex Whittington; Roger N Gunn
Journal:  J Nucl Med       Date:  2021-01-30       Impact factor: 10.057

2.  Image-level trajectory inference of tau pathology using variational autoencoder for Flortaucipir PET.

Authors:  Jimin Hong; Seung Kwan Kang; Ian Alberts; Jiaying Lu; Raphael Sznitman; Jae Sung Lee; Axel Rominger; Hongyoon Choi; Kuangyu Shi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-02-28       Impact factor: 10.057

3.  Synthesis and pharmacokinetic characterisation of a fluorine-18 labelled brain shuttle peptide fusion dimeric affibody.

Authors:  Takahiro Morito; Ryuichi Harada; Ren Iwata; Yiqing Du; Nobuyuki Okamura; Yukitsuka Kudo; Kazuhiko Yanai
Journal:  Sci Rep       Date:  2021-01-28       Impact factor: 4.379

Review 4.  Tauvid™: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer's Disease.

Authors:  Caitlin V M L Jie; Valerie Treyer; Roger Schibli; Linjing Mu
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-30

5.  Multicenter 18F-PI-2620 PET for In Vivo Braak Staging of Tau Pathology in Alzheimer's Disease.

Authors:  Michael Rullmann; Matthias Brendel; Matthias L Schroeter; Dorothee Saur; Johannes Levin; Robert G Perneczky; Solveig Tiepolt; Marianne Patt; Andre Mueller; Victor L Villemagne; Joseph Classen; Andrew W Stephens; Osama Sabri; Henryk Barthel
Journal:  Biomolecules       Date:  2022-03-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.